Company Filing History:
Years Active: 2017-2019
Title: Innovations and Contributions of Inventor Sergey Shulenin
Introduction
Sergey Shulenin is a notable inventor based in Point of Rocks, MD (US). He has made significant contributions to the field of immunology through his innovative research and development of immunogenic compositions. With a total of 3 patents to his name, Shulenin's work focuses on the prevention and treatment of infections.
Latest Patents
One of his latest patents is titled "Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof." This patent provides immunogenic compositions that are useful in preventing and treating infections. It specifically details delta toxin and phenol-soluble modulin peptides, along with their mutants, fragments, variants, or derivatives. Additionally, it discusses multivalent oligopeptides and fusion proteins that comprise two or more staphylococcal proteins, such as DT, PSM, alpha hemolysin, leukocidin, and superantigens, fused together as a single polypeptide.
Another significant patent is "Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides." This patent outlines methods for inducing an immune response against PVL-expressing pathogens, as well as compositions for preventing or treating infections caused by these pathogens.
Career Highlights
Sergey Shulenin is currently associated with Integrated Biotherapeutics, Inc., where he continues to advance his research in immunology. His work has been instrumental in developing new therapeutic strategies to combat infectious diseases.
Collaborations
Shulenin collaborates with esteemed colleagues, including Mohammad Javad Aman and Rajan Prasad Adhikari. These partnerships enhance the scope and impact of his research efforts.
Conclusion
In summary, Sergey Shulenin is a dedicated inventor whose work in immunogenic compositions has the potential to significantly improve infection prevention and treatment. His innovative patents reflect his commitment to advancing medical science and public health.